Potassium oxonate

Suppliers

Names

[ CAS No. ]:
2207-75-2

[ Name ]:
Potassium oxonate

[Synonym ]:
1,3,5-Triazine-2-carboxylic acid, 1,4,5,6-tetrahydro-4,6-dioxo-, potassium salt (1:1)
Allantoxanic acid
monopotassium 1,2,3,4-tetrahydro-2,4-dioxo-1,3,5-triazine-6-carboxylate
Potassium Oxonate
Oxonic acid potassium salt
Oxonic acid
Potassium 4,6-Dihydroxy-1,3,5-triazine-2-carboxylate
Potassium azaorotate
Oxonate
MFCD00010565
Potassium Allantoxanate
5-Aza-orotsaeure K-Salz
potassium 1,4,5,6-tetrahydro-4,6-dioxo-1,3,5-triazine-2-carboxylate
Potassium 4,6-dioxo-1,4,5,6-tetrahydro-1,3,5-triazine-2-carboxylate
Allantoxanic Acid Potassium Salt
Oxonic acid,potassium salt
Oteracil potassium
Oxonate,potassium
EINECS 218-627-5

Chemical & Physical Properties

[ Melting Point ]:
300 °C(lit.)

[ Molecular Formula ]:
C4H2KN3O4

[ Molecular Weight ]:
195.175

[ Exact Mass ]:
194.968231

[ PSA ]:
118.74000

[ Storage condition ]:
Refrigerator, Under Inert Atmosphere

MSDS

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
RR4580000
CHEMICAL NAME :
Oxonic acid, potassium salt
CAS REGISTRY NUMBER :
2207-75-2
LAST UPDATED :
199704
DATA ITEMS CITED :
3
MOLECULAR FORMULA :
C4-H3-N3-O4.K
MOLECULAR WEIGHT :
196.20
WISWESSER LINE NOTATION :
T6MVMVNJ FVO &-KA-

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
3 gm/kg
SEX/DURATION :
female 8-9 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Fertility - litter size (e.g. # fetuses per litter; measured before birth) Reproductive - Specific Developmental Abnormalities - body wall
REFERENCE :
TXCYAC Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- Volume(issue)/page/year: 6,299,1976
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
4500 mg/kg
SEX/DURATION :
female 8-10 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - Central Nervous System
REFERENCE :
TXCYAC Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- Volume(issue)/page/year: 6,299,1976
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
10800 ug/kg
SEX/DURATION :
female 9-11 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Fertility - litter size (e.g. # fetuses per litter; measured before birth)
REFERENCE :
TXCYAC Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- Volume(issue)/page/year: 6,289,1976

Safety Information

[ Hazard Codes ]:
Xn

[ Safety Phrases ]:
S24/25

[ WGK Germany ]:
3

[ RTECS ]:
RR4580000

[ HS Code ]:
2933699090

Synthetic Route

Precursor & DownStream

Precursor

  • 1-(2,5-Dioxo-2,5-dihydro-1H-imidazol-4-yl)urea

DownStream

Customs

[ HS Code ]: 2933699090

[ Summary ]:
2933699090 other compounds containing an unfused triazine ring (whether or not hydrogenated) in the structure。Supervision conditions:None。VAT:17.0%。Tax rebate rate:9.0%。MFN tariff:6.5%。General tariff:20.0%


Related Compounds

  • Gimeracil mixture with potassium oxonate and Tegafur
  • Potassium 2,3-dihydro-1H-inden-2-yl(trifluoro)borate(1-)
  • Potassium 2-deoxy-2-(sulfonatoamino)-D-glucose
  • potassium methyldithiocarbamate
  • potassium O,O-dibutyl dithiophosphate
  • Potassium (2,4-dimethylphenyl)trifluoroborate
  • 5-Bromo-2-methoxy-4-methylbenzene-1-sulfonyl chloride
  • (1-ethyl-1H-indol-4-yl)-N-methylmethanamine
  • (S)-1-(2-methylpyrimidin-5-yl)ethanamine
  • 3-Amino-3-(6-(trifluoromethyl)pyridin-3-yl)propan-1-ol
  • Benzeneacetamide, N-[3-oxo-3-[[4-(2-phenyldiazenyl)phenyl]amino]propyl]-
  • Cyclohexylethyl[(2-methoxy-4,5-dimethylphenyl)sulfonyl]amine
  • 4-(2-Nitroethyl)-1,2,3-thiadiazole
  • [(4-Bromo-3-methoxyphenyl)sulfonyl]cyclohexylethylamine
  • 1-Chloro-4-(indolinylsulfonyl)-2-methylbenzene
  • [(2-Methyl-5-nitrophenyl)sulfonyl](phenylethyl)amine